Table 4 |
|||
|
Concentrations of inflammatory mediators in synovial fluid and plasma from arthritic patients (n = 11) |
|||
|
Mediator |
Concentration |
P |
|
|
|
|||
|
Synovial fluid |
Plasma |
||
|
|
|||
|
MCP-1 (pg/ml) |
134 (36–522) |
34 (15–62) |
0.008 |
|
sICAM-1 (ng/ml) |
706 (226–1,085) |
871 (657–1,691) |
0.006 |
|
IL-8 (pg/ml) |
614 (<50–24,630) |
<50 |
0.002 |
|
IL-6 (pg/ml) |
13,897 (35–43,131) |
11 (0–57) |
0.002 |
|
VEGF (pg/ml) |
1,604 (528–2,506) |
23 (<5–69) |
0.002 |
|
RANTES (pg/ml) |
7 (<5–35) |
3,986 (2,920–10,037) |
0.001 |
|
GM-CSF (pg/ml) |
<2 (<2–39) |
<2 (<2–28) |
0.125 |
|
|
|||
|
Results are medians, with ranges in parentheses. Concentrations of all mediators were determined by ELISA as described in the Materials and methods section. GM-CSF, granulocyte/macrophage colony-stimulating factor; MCP-1, monocyte chemoattractant protein-1; sICAM-1, soluble intracellular adhesion molecule-1; VEGF, vascular endothelial growth factor. |
|||
|
Berckmans et al. Arthritis Research & Therapy 2005 7:R536 doi:10.1186/ar1706 |
|||